Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Choosing between cash back and points for travel can impact your rewards. Explore which option suits your travel style!
26,759 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
A new wave of tech IPOs is poised to influence index funds and passive strategies. Learn what it means for your portf...
Federal economists say tariffs are unlikely to be a one-off hit. Instead, a trump created ‘trickle up’ pricing approa...
SK hynix began trading in the U.S. on a when-issued basis under the SKHYV symbol, with the permanent SKHY ticker slat...
The AI gold rush has turbocharged demand for specialized chips. Morgan Stanley warns of chipflation as hyperscalers i...
Banks are expanding infrastructure to monetize Bitcoin exposure without holding coins. Strategy's 32% adoption score ...
Compass has filed ethics complaints against Zillow across 26 states, highlighting disputes over how active listings a...
Fed policy under Warsh signals a shift toward real-time data, nudging markets toward the near-term bond curve. Morgan...
A new plan to monetize Truth Social could let Wall Street traders see posts milliseconds before others. The move prom...
China’s DeepSeek AI forecasts notable upside for XRP, PEPE, and Shiba Inu through 2026, highlighting potential cataly...
The SPDR S&P Semiconductor ETF jumps roughly 12% amid resilient AI-related demand, yet Intel remains a weakness in an...
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...